Innate Immune Proteins C1q and Mannan-Binding Lectin Enhance Clearance of Atherogenic Lipoproteins by Human Monocytes and Macrophages
Open Access
- 1 October 2010
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 185 (7) , 3932-3939
Abstract
Atherosclerosis is a chronic inflammatory disorder that is characterized by the accumulation of modified lipoproteins in the arterial intima. C1q and mannan-binding lectin (MBL) are not only recognition components involved in activation of inflammation via the complement cascade, but they are also able to directly modulate phagocyte activation. Studies in C1q−/− and MBL−/− mice suggest that these molecules play a protective role in the early atherosclerotic lesion in the absence of, or prior to, expression of other complement components. However, in later stages, complement activation becomes an inappropriate inflammatory response, contributing to disease pathology. Therefore, to investigate possible molecular interactions of C1q and MBL in atherosclerotic lesions, we examined the influence of C1q and MBL in the clearance of native and modified lipoproteins by human monocytes and monocyte-derived macrophages. Both C1q and MBL are shown to bind and enhance the monocyte/monocyte-derived macrophage clearance of modified forms of low-density lipoprotein (LDL), including oxidized LDL and acetylated LDL, but not native LDL. Modified forms of LDL activate the classical complement pathway, but no lectin pathway activation was detected. Interestingly, monocytes that ingested modified LDL in the presence of C1q or MBL upregulated surface CD80 and CD31, as well as CCL2 chemokine gene expression. However, C1q and MBL also significantly reduced levels of free cholesterol accumulation in monocytes and human monocyte-derived macrophages that ingested oxidized LDL, while enhancing high-density lipoprotein–specific cholesterol efflux from these cells. These results suggest a novel pathway in which C1q and MBL influence removal and metabolism of atherogenic forms of LDL in the early stages of atherosclerosis.Keywords
This publication has 44 references indexed in Scilit:
- Complement Protein C1q Recognizes Enzymatically Modified Low-Density Lipoprotein through Unesterified Fatty Acids Generated by Cholesterol EsteraseBiochemistry, 2010
- Role of HDL, ABCA1, and ABCG1 Transporters in Cholesterol Efflux and Immune ResponsesArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- C1q Differentially Modulates Phagocytosis and Cytokine Responses during Ingestion of Apoptotic Cells by Human Monocytes, Macrophages, and Dendritic CellsThe Journal of Immunology, 2009
- Adiponectin reduces lipid accumulation in macrophage foam cellsAtherosclerosis, 2009
- Modified low density lipoproteins differentially bind and activate the C1 complex of complementMolecular Immunology, 2007
- Complement C1q Reduces Early Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient MiceThe American Journal of Pathology, 2007
- The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophagesNature Cell Biology, 2003
- Innate and acquired immunity in atherogenesisNature Medicine, 2002
- Characterization of Clq, Cls and Cl̄ Inh synthesized by stimulated human monocytes in vitroFEBS Letters, 1985
- Direct Demonstration and Quantitation of the First Complement Component in Human SerumScience, 1978